ADAMTS19
Basic information
Region (hg38): 5:129460281-129738683
Links
Phenotypes
GenCC
Source:
- cardiac valvular dysplasia 2 (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Cardiac valvular dysplasia 2 | AR | Cardiovascular | The condition can involve multiple types of cardiovascular anomalies, and awareness may allow early management | Cardiovascular | 31844321; 32323311 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (3 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ADAMTS19 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 5 | |||||
missense | 101 | 105 | ||||
nonsense | 2 | |||||
start loss | 0 | |||||
frameshift | 2 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 1 | 1 | ||||
non coding | 2 | |||||
Total | 3 | 0 | 104 | 7 | 4 |
Variants in ADAMTS19
This is a list of pathogenic ClinVar variants found in the ADAMTS19 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
5-129461108-A-T | Inborn genetic diseases | Uncertain significance (Dec 12, 2023) | ||
5-129461122-C-G | ADAMTS19-related disorder • Inborn genetic diseases | Uncertain significance (Nov 23, 2021) | ||
5-129461123-G-T | Inborn genetic diseases | Uncertain significance (Nov 21, 2022) | ||
5-129461137-G-A | Inborn genetic diseases | Uncertain significance (Dec 06, 2021) | ||
5-129461150-C-G | Inborn genetic diseases | Uncertain significance (Sep 09, 2021) | ||
5-129461150-C-T | Inborn genetic diseases | Uncertain significance (Feb 28, 2023) | ||
5-129461167-C-A | Inborn genetic diseases | Uncertain significance (Jun 22, 2021) | ||
5-129461176-C-A | Inborn genetic diseases | Likely benign (Aug 19, 2024) | ||
5-129461195-G-A | Inborn genetic diseases | Uncertain significance (Dec 03, 2024) | ||
5-129461227-G-C | Inborn genetic diseases | Uncertain significance (Jan 10, 2023) | ||
5-129461245-C-G | Inborn genetic diseases | Uncertain significance (Aug 28, 2024) | ||
5-129461245-CGG-C | Pathogenic (Jun 27, 2022) | |||
5-129461261-G-A | Inborn genetic diseases | Uncertain significance (May 29, 2024) | ||
5-129461279-GC-G | Pathogenic (Jun 27, 2022) | |||
5-129461311-G-A | Inborn genetic diseases | Uncertain significance (May 04, 2022) | ||
5-129461321-G-C | Inborn genetic diseases | Uncertain significance (Dec 13, 2022) | ||
5-129461345-C-T | Inborn genetic diseases | Uncertain significance (May 31, 2023) | ||
5-129461392-C-G | Inborn genetic diseases | Uncertain significance (Jun 29, 2023) | ||
5-129461417-C-A | not specified | Uncertain significance (Mar 29, 2024) | ||
5-129461426-C-G | Inborn genetic diseases | Uncertain significance (Dec 08, 2023) | ||
5-129461449-C-A | Inborn genetic diseases | Uncertain significance (Mar 31, 2022) | ||
5-129461462-C-T | Inborn genetic diseases | Uncertain significance (Jan 29, 2024) | ||
5-129461471-C-A | Inborn genetic diseases | Uncertain significance (Apr 23, 2024) | ||
5-129461485-C-T | Inborn genetic diseases | Uncertain significance (Apr 23, 2024) | ||
5-129461507-C-T | Inborn genetic diseases | Uncertain significance (Jun 10, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ADAMTS19 | protein_coding | protein_coding | ENST00000274487 | 23 | 278419 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
5.96e-8 | 1.00 | 125697 | 0 | 51 | 125748 | 0.000203 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.10 | 451 | 595 | 0.758 | 0.0000291 | 7814 |
Missense in Polyphen | 122 | 230.94 | 0.52828 | 2815 | ||
Synonymous | -0.0872 | 206 | 204 | 1.01 | 0.00000999 | 2277 |
Loss of Function | 4.54 | 24 | 62.9 | 0.382 | 0.00000344 | 768 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000268 | 0.000268 |
Ashkenazi Jewish | 0.000298 | 0.000298 |
East Asian | 0.0000550 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000259 | 0.000255 |
Middle Eastern | 0.0000550 | 0.0000544 |
South Asian | 0.000238 | 0.000229 |
Other | 0.000347 | 0.000326 |
dbNSFP
Source:
- Pathway
- Post-translational protein modification;Metabolism of proteins;O-glycosylation of TSR domain-containing proteins;O-linked glycosylation
(Consensus)
Recessive Scores
- pRec
- 0.106
Intolerance Scores
- loftool
- 0.440
- rvis_EVS
- -0.55
- rvis_percentile_EVS
- 19.93
Haploinsufficiency Scores
- pHI
- 0.336
- hipred
- Y
- hipred_score
- 0.685
- ghis
- 0.406
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.256
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Adamts19
- Phenotype
- homeostasis/metabolism phenotype; immune system phenotype; hematopoietic system phenotype;
Gene ontology
- Biological process
- proteolysis
- Cellular component
- extracellular region
- Molecular function
- metalloendopeptidase activity;metal ion binding